Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TROX | CE |
|---|---|---|
| Price | $3.71 | $43.86 |
| Change today | ▼ 4.13% | ▼ 2.21% |
| Market cap | $592.49M | $4.81B |
| Return, 3 months | -38.8% | -5.9% |
| Return, year to date | -9.2% | +3.9% |
| Return, 1 year | +4.2% | +3.1% |
| P/E (TTM) | -1.1 | -4.1 |
| P/B | 0.5 | 1.2 |
| P/E percentile vs own 5y | 64th | 12th |
| Dividend yield | 5.39% | 0.27% |
| Revenue growth (YoY, latest qtr) | +18.7% | +8.7% |
| Net profit growth (YoY) | -103.5% | -35.5% |
| Gross margin | 6.2% | 20.9% |
| Operating margin | -3.2% | 8.4% |
| Net margin | -18.0% | -12.0% |
| Return on equity | -39.1% | -24.8% |
| Analyst target vs. price | +65.2% | +34.3% |
| Analyst buy share | 20% | 58% |
| RSI (14) | 24 | 43 |
| 30-day volatility | 35.5% | 41.3% |
| Max drawdown, 1 year | -64.1% | -37.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
